Over the past few years, the life sciences industry has been accelerating at a rapid rate. From scientists developing innovative diagnostic processes for COVID-19 testing, to the discovery of a flurry ...

Curebase has raised $40 million in second-round financing that will help it run more complex interventional trials for its biopharma clients, according to chief executive Tom Lemberg. The Series B ...